Scarica l'app Stockscreener
3.06
4.08%
-0.13
Dopo l'orario di chiusura:
3.09
0.03
+0.98%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CABA Giù?
Forum
Previsione
Precedente Chiudi:
$3.19
Aprire:
$3.2
Volume 24 ore:
1.47M
Relative Volume:
0.51
Capitalizzazione di mercato:
$294.57M
Reddito:
-
Utile/perdita netta:
$-67.68M
Rapporto P/E:
-1.8434
EPS:
-1.66
Flusso di cassa netto:
$-54.24M
1 W Prestazione:
-3.47%
1M Prestazione:
+9.29%
6M Prestazione:
+66.30%
1 anno Prestazione:
+71.91%
Intervallo 1D:
$3.01
$3.2799
Intervallo di 1 settimana:
$3.01
$3.54
Portata 52W:
$0.9857
$3.78
Cabaletta Bio Inc Stock (CABA) Company Profile
Nome
Cabaletta Bio Inc
Settore
Industria
Telefono
(267) 759-3100
Indirizzo
2929 ARCH STREET, PHILADELPHIA, PA
Compare CABA vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CABA
Cabaletta Bio Inc
|
3.06 | 294.57M | 0 | -67.68M | -54.24M | -1.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Cabaletta Bio Inc Stock (CABA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-10 | Ripresa | Jefferies | Buy |
| 2024-12-20 | Downgrade | Evercore ISI | Outperform → In-line |
| 2024-12-19 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-10-10 | Iniziato | UBS | Buy |
| 2024-02-05 | Iniziato | Jefferies | Buy |
| 2023-11-29 | Iniziato | William Blair | Outperform |
| 2023-10-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-10-19 | Iniziato | Stifel | Buy |
| 2023-09-05 | Iniziato | Citigroup | Buy |
| 2023-07-18 | Iniziato | Guggenheim | Buy |
| 2023-01-27 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-08-30 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-08 | Iniziato | Wells Fargo | Overweight |
| 2021-10-19 | Ripresa | Morgan Stanley | Overweight |
| 2021-06-30 | Iniziato | Mizuho | Buy |
| 2021-01-08 | Iniziato | Chardan Capital Markets | Buy |
| 2020-10-13 | Iniziato | H.C. Wainwright | Buy |
| 2019-11-19 | Iniziato | Cowen | Outperform |
| 2019-11-19 | Iniziato | Evercore ISI | Outperform |
| 2019-11-19 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Cabaletta Bio Inc Borsa (CABA) Ultime notizie
Cabaletta Bio (CABA) upgraded to buy: Here's what you should know - MSN
Cabaletta Bio Highlights Pivotal Myositis Trial, No-Preconditioning CAR-T Push at TD Cowen Conference - MarketBeat
Day Trade: What are Cabaletta Bio Inc.’s recent SEC filings showingJuly 2025 Sector Moves & Free Reliable Trade Execution Plans - baoquankhu1.vn
Cabaletta Bio takes spotlight at Guggenheim Summit as autoimmune bet advances - MSN
Cabaletta Bio (CABA) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Cabaletta Bio (CABA) to Release Quarterly Earnings on Thursday - MarketBeat
CABA SEC FilingsCabaletta Bio, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
TD Cowen Health Care Conference - marketscreener.com
Are healthcare stocks underperforming Biodesix (BDSX) so far this year? - Bitget
Are Medical Stocks Lagging Biodesix (BDSX) This Year? - Yahoo Finance
Cabaletta Bio (CABA) grants 225,000 stock options to its president - Stock Titan
Cabaletta Bio (CABA) CEO awarded 674,000-share stock option grant - Stock Titan
Cabaletta Bio (CABA) grants 175,000 stock options to Chief Business Officer - Stock Titan
Gains Report: Can Cabaletta Bio Inc deliver consistent dividendsJuly 2025 Analyst Calls & Fast Gain Swing Alerts - baoquankhu1.vn
CABA Should I Buy - Intellectia AI
CABA Technical Analysis & ETF Price Forecast - Intellectia AI
Here’s why Jacob Funds established a position in Cabaletta Bio (CABA) - MSN
Millennium Management LLC's Strategic Acquisition of Cabaletta B - GuruFocus
Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference - The Manila Times
Short Covering: Will Cabaletta Bio Inc announce a stock split2025 Price Targets & Scalable Portfolio Growth Methods - baoquankhu1.vn
Aug EndMonth: What drives SATLWs stock price2025 Market Sentiment & Stock Market Timing Techniques - baoquankhu1.vn
Dividend Watch: Is PECO stock a falling knife or bargain buyRisk Management & Growth Oriented Trade Recommendations - baoquankhu1.vn
CABA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Cabaletta Bio, Inc. (NASDAQ:CABA) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Market Rankings: Is Cabaletta Bio Inc stock trending bullishJuly 2025 Analyst Calls & High Accuracy Swing Trade Signals - baoquankhu1.vn
Millennium Group (CABA) jointly reports 5.3% holding of 5.13M shares - Stock Titan
Aug Shorts: Does Cabaletta Bio Inc have strong EBITDA marginsJuly 2025 Update & Accurate Buy Signal Notifications - baoquankhu1.vn
Here’s Why Jacob Funds Established a Position in Cabaletta Bio (CABA) - Insider Monkey
Alyeska group reports 4.67% Cabaletta Bio (CABA) stake via 4.5M warrants - Stock Titan
What are Cabaletta Bio Inc.’s recent SEC filings showingPortfolio Update Summary & Daily Risk Controlled Trade Plans - mfd.ru
CABA News & Events - Intellectia AI
Best Swing Trade Stocks Right Now • Updated Daily - Benzinga
Pharma News: Why retail investors favor Cabaletta Bio Inc. stock2025 Historical Comparison & Fast Entry High Yield Tips - mfd.ru
Cabaletta Bio Kicks Off Pivotal Myositis Trial, Touts Automated CAR-T Manufacturing Path to 2027 BLA - MarketBeat
Is Anavex Life Sciences (AVXL) Stock Outpacing Its Medical Peers This Year? - Nasdaq
Aug Drivers: Is Cabaletta Bio Inc stock a smart retirement pickJuly 2025 Recap & Fast Moving Market Watchlists - baoquankhu1.vn
CABA News Today | Why did Cabaletta Bio stock go up today? - MarketBeat
Cabaletta Bio Takes Spotlight at Guggenheim Summit as Autoimmune Bet Advances - MyChesCo
Cabaletta Bio shares climb after insider purchases - MSN
Update Recap: Is Cabaletta Bio Inc stock overvalued or fairly priced2025 Macro Impact & AI Powered Market Entry Strategies - baoquankhu1.vn
Trend Review: Is Cabaletta Bio Inc stock overvalued or fairly pricedJuly 2025 Technicals & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - The Globe and Mail
Cabaletta Bio to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026 - Quiver Quantitative
Risk Off: What is Cabaletta Bio Incs P E ratio telling usJuly 2025 PostEarnings & Weekly High Return Stock Forecasts - baoquankhu1.vn
Swing Trade: Can Cabaletta Bio Inc deliver consistent dividendsQuarterly Earnings Summary & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
US Market Wrap: Can Cabaletta Bio Inc disrupt its industryJuly 2025 Outlook & Reliable Entry Point Alerts - baoquankhu1.vn
Highs Report: Will Tucows Inc outperform its industry peersMarket Activity Recap & Fast Moving Stock Trade Plans - baoquankhu1.vn
What makes Cabaletta Bio, Inc. (CABA) a strong momentum stock: Buy now? - MSN
Cabaletta Bio Inc Azioni (CABA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):